It is not a secret that cannabis industry is candidate #1 for top performer of 2018. Several market leaders' stock prices have broken their resistance levels recently. One of them is OrganiGram Holdings Inc. OrganiGram stock is making a run for it, off of positive momentum from OrganiGram Holdings' recent Q2 results. Get the details inside. Organigram Holdings Inc. is a Nasdaq and TSX Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Top Balanced Bottled Oil Winner: Midnight Oil - MedReleaf Finalist: Utopia - Organigram Finalist: Reign Drops 15:15 - Redecan
OrganiGram stock is making a run for it, off of positive momentum from OrganiGram Holdings' recent Q2 results. Get the details inside.
Nejnovější tweety od uživatele La Bomba CBD (@LaBombaCBD). La Bomba CBD Hemp Oil is derived from specially bred, organically grown Industrial Hemp plants with high CBD content that is CO2 extracted. #FollowBack. A selloff that kicked off in September has brought Organigram Holdings Inc. (TSE:OGI) (Nasdaq:OGI) down to one of its lowest price levels in more than one year. The agreement with Eviana will provide Organigram with a source of low-cost, high-quality CBD for the burgeoning medical market within Europe. Moncton, NEW Brunswick – May 17, 2018/CNW/ ‐ Organigram Holdings Inc. (TSX Venture:OGI) (Otcqb:Ogrmf) (the “Company” or “Organigram”), a leading licensed producer of medical marijuana based in Monc… Moncton, New Brunswick – Organigram Holdings Inc. (Nasdaq:OGI) (TSX:OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to… Listed as having 14% THC and less than 1% CBD, this mid-potency strain makes it possible to relax after a long day. Above all, Hunter’s Corner is incredibly calming.
Baleen is a CBD Shark phenotype produced by Organigram with a CBD to THC ratio of 2:1. Strain genetics come from the crossing of Shark Shock with
We are excited to announce that we have completed our first large harvest from one of our new flowering rooms, allowing us to consistently supply quality Citing Ontario’s slow cannabis retail build-out, Organigram Holdings issued revenue guidance for expected fourth-quarter net revenue of 16.3 million Canadian dollars ($12.3 million), a substantial decline from the previous quarter’s CA$24.8… Post Views: 134 Organigram Holdings Inc (CVE:OGI) is undergoing a manufacturing facility expansion that will over triple the magnitude of its operations. The multi-million-dollar assignment will fulfill the growing requirements of the firm…
Moncton, New Brunswick – Organigram Holdings Inc. (Nasdaq:OGI) (TSX:OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to…
Organigram is a leading Canadian licensed producer of high-quality medical and recreational cannabis. Organigram Holdings Inc (CVE:OGI)(Otcmkts:Ogrmf) CEO Greg Engel joins James for an update on the buildout of the company's next phase of growing capacity, and emphasizes their preparation for Canada's legal recreational marijuana market… At OrganiGram, our mission is to be the leading producer of organically grown medical marijuana. By combining advanced technologies and proven methods, we assure a secure and regulated source of medical marijuana for patients and doctors in… Our Story It’s a pretty good one if we do say so ourselves. Strong Roots Strong roots are important. Not just in our plants, but in our company as well. From the day we started back in 2013, we’ve invested in the continuous growth of our… For now, OrganiGram is primarily focused on the U.S. CBD industry, because of the legal framework established by the 2018 Farm Bill. We are excited to announce that we have completed our first large harvest from one of our new flowering rooms, allowing us to consistently supply quality